Full Text View
Tabular View
No Study Results Posted
Related Studies
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
This study has been completed.
Study NCT00244244   Information provided by CytRx

First Received on October 25, 2005.   Last Updated on February 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amyotrophic Lateral Sclerosis (ALS)
Additional conditions recognized in this trial
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Metabolic Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Pathologic Processes
Proteostasis Deficiencies
Spinal Cord Diseases
TDP-43 Proteinopathies
Interventions listed in this trial
arimoclomol
Sponsors listed in this trial
CytRx


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services